Skip to main content
TELA
NASDAQ Industrial Applications And Services

Shareholders Approve 3.5M Share Increase for Equity Incentive Plan, Potential 7.8% Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.911
Mkt Cap
$40.827M
52W Low
$0.501
52W High
$2.2
52W Position info
82% above low
Off High info
59% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

TELA sits 82% above its 52-week low of $0.501.

Summary

TELA Bio shareholders approved an amendment to its equity incentive plan, authorizing an additional 3.5 million shares for issuance, which represents a potential dilution of 7.8% for existing shareholders.


Key Events · Corporate Governance and Compliance · TELA

  • Equity Incentive Plan Expanded

    Stockholders approved an amendment to the 2019 Equity Incentive Plan, authorizing an additional 3,500,000 shares for issuance.

  • Potential Dilution

    If all newly authorized shares were issued, existing shareholders would face a potential dilution of 7.82% based on 44,765,928 outstanding shares as of April 24, 2026.

  • Governance Improvement

    The amendment includes a prohibition on repricing outstanding options or stock appreciation rights without further stockholder approval.


Analysis · TELA · Industrial Applications And Services

This 8-K confirms shareholder approval for a significant increase in TELA Bio's equity incentive plan, allowing the company to authorize an additional 3.5 million shares. This move, which was previously proposed in an April 30, 2026 proxy statement, is critical for TELA Bio to attract and retain talent, especially as it navigates financial challenges, including a Nasdaq delisting notice and negative stockholders' equity. While the potential dilution of 7.82% is notable for existing shareholders, the amendment also introduces a positive governance measure by prohibiting the repricing of options without further shareholder consent.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.2% of the 1961 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TELA was trading at $0.91 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $40.8M. The 52-week trading range was $0.50 to $2.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TELA - Latest Insights

TELA
Sep 04, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8215
Real-time Price: $0.9226 info
Change: +$0.1011 (+12%) info
Market Cap: $41.42M info
TELA
Aug 31, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6611
Real-time Price: $0.9226 info
Change: +$0.2615 (+40%) info
Market Cap: $41.42M info
TELA
Aug 11, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.790
Real-time Price: $0.9226 info
Change: +$0.1326 (+17%) info
Market Cap: $41.42M info
TELA
Aug 10, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.930
Real-time Price: $0.9226 info
Change: -$0.0074 (-0.80%) info
Market Cap: $41.42M info
TELA
Aug 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.9135
Real-time Price: $0.9226 info
Change: +$0.0091 (+1.00%) info
Market Cap: $41.42M info